HEADER TRANSFERASE 04-FEB-04 1S9I
TITLE X-RAY STRUCTURE OF THE HUMAN MITOGEN-ACTIVATED PROTEIN KINASE KINASE 2
TITLE 2 (MEK2)IN A COMPLEX WITH LIGAND AND MGATP
COMPND MOL_ID: 1;
COMPND 2 MOLECULE: DUAL SPECIFICITY MITOGEN-ACTIVATED PROTEIN KINASE KINASE 2;
COMPND 3 CHAIN: A, B;
COMPND 4 SYNONYM: MAP KINASE KINASE 2, MAPKK 2, ERK ACTIVATOR KINASE 2,
COMPND 5 MAPK/ERK KINASE 2, MEK2;
COMPND 6 EC: 2.7.1.37;
COMPND 7 ENGINEERED: YES
SOURCE MOL_ID: 1;
SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS;
SOURCE 3 ORGANISM_COMMON: HUMAN;
SOURCE 4 ORGANISM_TAXID: 9606;
SOURCE 5 GENE: MAP2K2, PRKMK2, MEK2, MKK2;
SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI BL21(DE3);
SOURCE 7 EXPRESSION_SYSTEM_TAXID: 469008;
SOURCE 8 EXPRESSION_SYSTEM_STRAIN: BL21(DE3);
SOURCE 9 EXPRESSION_SYSTEM_VECTOR: PLASMID;
SOURCE 10 EXPRESSION_SYSTEM_PLASMID: PET24B
KEYWDS PROTEIN KINASE-LIGAND-MGATP COMPLEX, PROTEIN-PROTEIN INTERACTIONS,
KEYWDS 2 TRANSFERASE
EXPDTA X-RAY DIFFRACTION
AUTHOR J.F.OHREN,H.CHEN,A.PAVLOVSKY,C.WHITEHEAD,C.YAN,P.MCCONNELL,A.DELANEY,
AUTHOR 2 D.T.DUDLEY,J.SEBOLT-LEOPOLD,C.A.HASEMANN
REVDAT 5 03-APR-24 1S9I 1 REMARK
REVDAT 4 14-FEB-24 1S9I 1 REMARK SEQADV LINK
REVDAT 3 24-FEB-09 1S9I 1 VERSN
REVDAT 2 14-DEC-04 1S9I 1 JRNL
REVDAT 1 23-NOV-04 1S9I 0
JRNL AUTH J.F.OHREN,H.CHEN,A.PAVLOVSKY,C.WHITEHEAD,E.ZHANG,P.KUFFA,
JRNL AUTH 2 C.YAN,P.MCCONNELL,C.SPESSARD,C.BANOTAI,W.T.MUELLER,
JRNL AUTH 3 A.DELANEY,C.OMER,J.SEBOLT-LEOPOLD,D.T.DUDLEY,I.K.LEUNG,
JRNL AUTH 4 C.FLAMME,J.WARMUS,M.KAUFMAN,S.BARRETT,H.TECLE,C.A.HASEMANN
JRNL TITL STRUCTURES OF HUMAN MAP KINASE KINASE 1 (MEK1) AND MEK2
JRNL TITL 2 DESCRIBE NOVEL NONCOMPETITIVE KINASE INHIBITION.
JRNL REF NAT.STRUCT.MOL.BIOL. V. 11 1192 2004
JRNL REFN ISSN 1545-9993
JRNL PMID 15543157
JRNL DOI 10.1038/NSMB859
REMARK 2
REMARK 2 RESOLUTION. 3.20 ANGSTROMS.
REMARK 3
REMARK 3 REFINEMENT.
REMARK 3 PROGRAM : REFMAC 5.1.24
REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER,
REMARK 3 : NICHOLLS,WINN,LONG,VAGIN
REMARK 3
REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD
REMARK 3
REMARK 3 DATA USED IN REFINEMENT.
REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 3.20
REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 14.40
REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL
REMARK 3 COMPLETENESS FOR RANGE (%) : 99.9
REMARK 3 NUMBER OF REFLECTIONS : 15147
REMARK 3
REMARK 3 FIT TO DATA USED IN REFINEMENT.
REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT
REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM
REMARK 3 R VALUE (WORKING + TEST SET) : 0.294
REMARK 3 R VALUE (WORKING SET) : 0.290
REMARK 3 FREE R VALUE : 0.364
REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.000
REMARK 3 FREE R VALUE TEST SET COUNT : 802
REMARK 3
REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN.
REMARK 3 TOTAL NUMBER OF BINS USED : 20
REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 3.20
REMARK 3 BIN RESOLUTION RANGE LOW (A) : 3.28
REMARK 3 REFLECTION IN BIN (WORKING SET) : 1055
REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : NULL
REMARK 3 BIN R VALUE (WORKING SET) : 0.3350
REMARK 3 BIN FREE R VALUE SET COUNT : 52
REMARK 3 BIN FREE R VALUE : 0.4820
REMARK 3
REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT.
REMARK 3 PROTEIN ATOMS : 4686
REMARK 3 NUCLEIC ACID ATOMS : 0
REMARK 3 HETEROGEN ATOMS : 126
REMARK 3 SOLVENT ATOMS : 0
REMARK 3
REMARK 3 B VALUES.
REMARK 3 FROM WILSON PLOT (A**2) : NULL
REMARK 3 MEAN B VALUE (OVERALL, A**2) : 41.69
REMARK 3 OVERALL ANISOTROPIC B VALUE.
REMARK 3 B11 (A**2) : -1.36000
REMARK 3 B22 (A**2) : -1.36000
REMARK 3 B33 (A**2) : 2.04000
REMARK 3 B12 (A**2) : -0.68000
REMARK 3 B13 (A**2) : 0.00000
REMARK 3 B23 (A**2) : 0.00000
REMARK 3
REMARK 3 ESTIMATED OVERALL COORDINATE ERROR.
REMARK 3 ESU BASED ON R VALUE (A): NULL
REMARK 3 ESU BASED ON FREE R VALUE (A): 0.667
REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.534
REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 30.110
REMARK 3
REMARK 3 CORRELATION COEFFICIENTS.
REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.850
REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.772
REMARK 3
REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT
REMARK 3 BOND LENGTHS REFINED ATOMS (A): 4889 ; 0.007 ; 0.021
REMARK 3 BOND LENGTHS OTHERS (A): NULL ; NULL ; NULL
REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 6601 ; 1.217 ; 1.999
REMARK 3 BOND ANGLES OTHERS (DEGREES): NULL ; NULL ; NULL
REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 588 ; 5.435 ; 5.000
REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): NULL ; NULL ; NULL
REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): NULL ; NULL ; NULL
REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): NULL ; NULL ; NULL
REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 718 ; 0.072 ; 0.200
REMARK 3 GENERAL PLANES REFINED ATOMS (A): 3655 ; 0.002 ; 0.020
REMARK 3 GENERAL PLANES OTHERS (A): NULL ; NULL ; NULL
REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): 2388 ; 0.195 ; 0.200
REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL
REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): NULL ; NULL ; NULL
REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL
REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): 142 ; 0.130 ; 0.200
REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL
REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL
REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL
REMARK 3 SYMMETRY VDW REFINED ATOMS (A): 30 ; 0.182 ; 0.200
REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL
REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): 1 ; 0.049 ; 0.200
REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL
REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL
REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL
REMARK 3
REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT
REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 2953 ; 0.355 ; 1.500
REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL
REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 4774 ; 0.659 ; 2.000
REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL
REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 1936 ; 0.646 ; 3.000
REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL
REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): 1827 ; 1.175 ; 4.500
REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL
REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL
REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL
REMARK 3
REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT
REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL
REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL
REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL
REMARK 3
REMARK 3 NCS RESTRAINTS STATISTICS
REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL
REMARK 3
REMARK 3 TLS DETAILS
REMARK 3 NUMBER OF TLS GROUPS : NULL
REMARK 3
REMARK 3 BULK SOLVENT MODELLING.
REMARK 3 METHOD USED : BABINET MODEL WITH MASK
REMARK 3 PARAMETERS FOR MASK CALCULATION
REMARK 3 VDW PROBE RADIUS : 1.40
REMARK 3 ION PROBE RADIUS : 0.80
REMARK 3 SHRINKAGE RADIUS : 0.80
REMARK 3
REMARK 3 OTHER REFINEMENT REMARKS: MAXIMUM LIKELIHOOD REFINEMENT USING
REMARK 3 REFMAC 5.1.24
REMARK 4
REMARK 4 1S9I COMPLIES WITH FORMAT V. 3.30, 13-JUL-11
REMARK 100
REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 10-FEB-04.
REMARK 100 THE DEPOSITION ID IS D_1000021536.
REMARK 200
REMARK 200 EXPERIMENTAL DETAILS
REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION
REMARK 200 DATE OF DATA COLLECTION : 02-AUG-02
REMARK 200 TEMPERATURE (KELVIN) : 100.0
REMARK 200 PH : 7.00
REMARK 200 NUMBER OF CRYSTALS USED : 1
REMARK 200
REMARK 200 SYNCHROTRON (Y/N) : Y
REMARK 200 RADIATION SOURCE : APS
REMARK 200 BEAMLINE : 17-ID
REMARK 200 X-RAY GENERATOR MODEL : NULL
REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M
REMARK 200 WAVELENGTH OR RANGE (A) : 1.000
REMARK 200 MONOCHROMATOR : SAGITALLY FOCUSED SI(111)
REMARK 200 OPTICS : NULL
REMARK 200
REMARK 200 DETECTOR TYPE : CCD
REMARK 200 DETECTOR MANUFACTURER : MARRESEARCH
REMARK 200 INTENSITY-INTEGRATION SOFTWARE : TRUNCATE, HKL-2000
REMARK 200 DATA SCALING SOFTWARE : CCP4 (TRUNCATE)
REMARK 200
REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 15147
REMARK 200 RESOLUTION RANGE HIGH (A) : 3.200
REMARK 200 RESOLUTION RANGE LOW (A) : 14.400
REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.000
REMARK 200
REMARK 200 OVERALL.
REMARK 200 COMPLETENESS FOR RANGE (%) : 99.9
REMARK 200 DATA REDUNDANCY : 9.800
REMARK 200 R MERGE (I) : 0.08800
REMARK 200 R SYM (I) : NULL
REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 25.6000
REMARK 200
REMARK 200 IN THE HIGHEST RESOLUTION SHELL.
REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 3.20
REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 3.28
REMARK 200 COMPLETENESS FOR SHELL (%) : 1.0
REMARK 200 DATA REDUNDANCY IN SHELL : NULL
REMARK 200 R MERGE FOR SHELL (I) : 0.36800
REMARK 200 R SYM FOR SHELL (I) : NULL
REMARK 200 <I/SIGMA(I)> FOR SHELL : 6.000
REMARK 200
REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH
REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT
REMARK 200 SOFTWARE USED: MOLREP
REMARK 200 STARTING MODEL: HUMAN MAP2K1
REMARK 200
REMARK 200 REMARK: NULL
REMARK 280
REMARK 280 CRYSTAL
REMARK 280 SOLVENT CONTENT, VS (%): 58.12
REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.94
REMARK 280
REMARK 280 CRYSTALLIZATION CONDITIONS: SODIUM / POTASSIUM PHOSPHATE, DTT, PH
REMARK 280 7, VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 288K, PH 7.00
REMARK 290
REMARK 290 CRYSTALLOGRAPHIC SYMMETRY
REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 61 2 2
REMARK 290
REMARK 290 SYMOP SYMMETRY
REMARK 290 NNNMMM OPERATOR
REMARK 290 1555 X,Y,Z
REMARK 290 2555 -Y,X-Y,Z+1/3
REMARK 290 3555 -X+Y,-X,Z+2/3
REMARK 290 4555 -X,-Y,Z+1/2
REMARK 290 5555 Y,-X+Y,Z+5/6
REMARK 290 6555 X-Y,X,Z+1/6
REMARK 290 7555 Y,X,-Z+1/3
REMARK 290 8555 X-Y,-Y,-Z
REMARK 290 9555 -X,-X+Y,-Z+2/3
REMARK 290 10555 -Y,-X,-Z+5/6
REMARK 290 11555 -X+Y,Y,-Z+1/2
REMARK 290 12555 X,X-Y,-Z+1/6
REMARK 290
REMARK 290 WHERE NNN -> OPERATOR NUMBER
REMARK 290 MMM -> TRANSLATION VECTOR
REMARK 290
REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS
REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM
REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY
REMARK 290 RELATED MOLECULES.
REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000
REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000
REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000
REMARK 290 SMTRY1 2 -0.500000 -0.866025 0.000000 0.00000
REMARK 290 SMTRY2 2 0.866025 -0.500000 0.000000 0.00000
REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 40.99533
REMARK 290 SMTRY1 3 -0.500000 0.866025 0.000000 0.00000
REMARK 290 SMTRY2 3 -0.866025 -0.500000 0.000000 0.00000
REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 81.99067
REMARK 290 SMTRY1 4 -1.000000 0.000000 0.000000 0.00000
REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 0.00000
REMARK 290 SMTRY3 4 0.000000 0.000000 1.000000 61.49300
REMARK 290 SMTRY1 5 0.500000 0.866025 0.000000 0.00000
REMARK 290 SMTRY2 5 -0.866025 0.500000 0.000000 0.00000
REMARK 290 SMTRY3 5 0.000000 0.000000 1.000000 102.48833
REMARK 290 SMTRY1 6 0.500000 -0.866025 0.000000 0.00000
REMARK 290 SMTRY2 6 0.866025 0.500000 0.000000 0.00000
REMARK 290 SMTRY3 6 0.000000 0.000000 1.000000 20.49767
REMARK 290 SMTRY1 7 -0.500000 0.866025 0.000000 0.00000
REMARK 290 SMTRY2 7 0.866025 0.500000 0.000000 0.00000
REMARK 290 SMTRY3 7 0.000000 0.000000 -1.000000 40.99533
REMARK 290 SMTRY1 8 1.000000 0.000000 0.000000 0.00000
REMARK 290 SMTRY2 8 0.000000 -1.000000 0.000000 0.00000
REMARK 290 SMTRY3 8 0.000000 0.000000 -1.000000 0.00000
REMARK 290 SMTRY1 9 -0.500000 -0.866025 0.000000 0.00000
REMARK 290 SMTRY2 9 -0.866025 0.500000 0.000000 0.00000
REMARK 290 SMTRY3 9 0.000000 0.000000 -1.000000 81.99067
REMARK 290 SMTRY1 10 0.500000 -0.866025 0.000000 0.00000
REMARK 290 SMTRY2 10 -0.866025 -0.500000 0.000000 0.00000
REMARK 290 SMTRY3 10 0.000000 0.000000 -1.000000 102.48833
REMARK 290 SMTRY1 11 -1.000000 0.000000 0.000000 0.00000
REMARK 290 SMTRY2 11 0.000000 1.000000 0.000000 0.00000
REMARK 290 SMTRY3 11 0.000000 0.000000 -1.000000 61.49300
REMARK 290 SMTRY1 12 0.500000 0.866025 0.000000 0.00000
REMARK 290 SMTRY2 12 0.866025 -0.500000 0.000000 0.00000
REMARK 290 SMTRY3 12 0.000000 0.000000 -1.000000 20.49767
REMARK 290
REMARK 290 REMARK: NULL
REMARK 300
REMARK 300 BIOMOLECULE: 1
REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM
REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN
REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON
REMARK 300 BURIED SURFACE AREA.
REMARK 300 REMARK: THE NH2-TRUNCATED MEK2 IS A HOMODIMER IN SOLUTION AND IN
REMARK 300 THE CRYSTALLOGRAPHIC ASU. MEK2 MAY FORM A FUNCTIONAL DIMER IN VIVO.
REMARK 350
REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN
REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE
REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS
REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND
REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN.
REMARK 350
REMARK 350 BIOMOLECULE: 1
REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC
REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC
REMARK 350 SOFTWARE USED: PISA
REMARK 350 TOTAL BURIED SURFACE AREA: 5500 ANGSTROM**2
REMARK 350 SURFACE AREA OF THE COMPLEX: 28410 ANGSTROM**2
REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -31.0 KCAL/MOL
REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B
REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000
REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000
REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000
REMARK 465
REMARK 465 MISSING RESIDUES
REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE
REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN
REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.)
REMARK 465
REMARK 465 M RES C SSSEQI
REMARK 465 GLU A 55
REMARK 465 ALA A 56
REMARK 465 PHE A 57
REMARK 465 LEU A 58
REMARK 465 THR A 59
REMARK 465 ALA A 224
REMARK 465 ASN A 225
REMARK 465 SER A 226
REMARK 465 PHE A 227
REMARK 465 GLY A 286
REMARK 465 GLU A 287
REMARK 465 GLU A 288
REMARK 465 GLY A 289
REMARK 465 GLU A 290
REMARK 465 PRO A 291
REMARK 465 HIS A 292
REMARK 465 SER A 293
REMARK 465 ILE A 294
REMARK 465 SER A 295
REMARK 465 PRO A 296
REMARK 465 ARG A 297
REMARK 465 PRO A 298
REMARK 465 ARG A 299
REMARK 465 PRO A 300
REMARK 465 PRO A 301
REMARK 465 GLY A 302
REMARK 465 ARG A 303
REMARK 465 PRO A 304
REMARK 465 VAL A 305
REMARK 465 SER A 306
REMARK 465 GLY A 307
REMARK 465 HIS A 308
REMARK 465 GLY A 309
REMARK 465 MET A 310
REMARK 465 ASP A 311
REMARK 465 SER A 312
REMARK 465 THR A 394
REMARK 465 PRO A 395
REMARK 465 THR A 396
REMARK 465 ARG A 397
REMARK 465 THR A 398
REMARK 465 ALA A 399
REMARK 465 VAL A 400
REMARK 465 LEU A 401
REMARK 465 GLU A 402
REMARK 465 HIS A 403
REMARK 465 HIS A 404
REMARK 465 HIS A 405
REMARK 465 HIS A 406
REMARK 465 HIS A 407
REMARK 465 HIS A 408
REMARK 465 GLU B 55
REMARK 465 ALA B 56
REMARK 465 PHE B 57
REMARK 465 LEU B 58
REMARK 465 ALA B 224
REMARK 465 ASN B 225
REMARK 465 SER B 226
REMARK 465 PHE B 227
REMARK 465 VAL B 228
REMARK 465 GLY B 229
REMARK 465 PRO B 282
REMARK 465 VAL B 283
REMARK 465 VAL B 284
REMARK 465 ASP B 285
REMARK 465 GLY B 286
REMARK 465 GLU B 287
REMARK 465 GLU B 288
REMARK 465 GLY B 289
REMARK 465 GLU B 290
REMARK 465 PRO B 291
REMARK 465 HIS B 292
REMARK 465 SER B 293
REMARK 465 ILE B 294
REMARK 465 SER B 295
REMARK 465 PRO B 296
REMARK 465 ARG B 297
REMARK 465 PRO B 298
REMARK 465 ARG B 299
REMARK 465 PRO B 300
REMARK 465 PRO B 301
REMARK 465 GLY B 302
REMARK 465 ARG B 303
REMARK 465 PRO B 304
REMARK 465 VAL B 305
REMARK 465 SER B 306
REMARK 465 GLY B 307
REMARK 465 HIS B 308
REMARK 465 GLY B 309
REMARK 465 MET B 310
REMARK 465 ASP B 311
REMARK 465 SER B 312
REMARK 465 ARG B 313
REMARK 465 PRO B 314
REMARK 465 ALA B 315
REMARK 465 ASN B 390
REMARK 465 GLN B 391
REMARK 465 PRO B 392
REMARK 465 GLY B 393
REMARK 465 THR B 394
REMARK 465 PRO B 395
REMARK 465 THR B 396
REMARK 465 ARG B 397
REMARK 465 THR B 398
REMARK 465 ALA B 399
REMARK 465 VAL B 400
REMARK 465 LEU B 401
REMARK 465 GLU B 402
REMARK 465 HIS B 403
REMARK 465 HIS B 404
REMARK 465 HIS B 405
REMARK 465 HIS B 406
REMARK 465 HIS B 407
REMARK 465 HIS B 408
REMARK 500
REMARK 500 GEOMETRY AND STEREOCHEMISTRY
REMARK 500 SUBTOPIC: TORSION ANGLES
REMARK 500
REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS:
REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER;
REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE).
REMARK 500
REMARK 500 STANDARD TABLE:
REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2)
REMARK 500
REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI-
REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400
REMARK 500
REMARK 500 M RES CSSEQI PSI PHI
REMARK 500 VAL A 64 -52.53 -126.46
REMARK 500 ILE A 75 -72.93 -104.91
REMARK 500 PRO A 93 34.55 -93.44
REMARK 500 SER A 94 -27.13 -159.75
REMARK 500 GLU A 106 -83.54 -67.19
REMARK 500 LYS A 108 37.16 -141.46
REMARK 500 PRO A 109 -140.55 -95.37
REMARK 500 VAL A 121 -8.08 -57.56
REMARK 500 PRO A 128 5.15 -63.11
REMARK 500 LYS A 163 -102.00 -68.00
REMARK 500 ASP A 194 53.33 -162.57
REMARK 500 ARG A 231 119.99 -174.34
REMARK 500 GLN A 240 21.01 -79.18
REMARK 500 PRO A 282 101.53 -55.37
REMARK 500 VAL A 284 -139.70 -158.79
REMARK 500 VAL A 326 -71.21 -70.36
REMARK 500 ASP A 378 90.35 -69.20
REMARK 500 ASN A 390 108.58 -37.70
REMARK 500 PRO A 392 63.48 -67.95
REMARK 500 LYS B 61 39.89 -88.39
REMARK 500 PRO B 109 75.36 -64.94
REMARK 500 ALA B 110 -53.29 -164.72
REMARK 500 PRO B 128 2.03 -60.93
REMARK 500 ASP B 140 85.35 -64.86
REMARK 500 HIS B 188 -6.28 -140.61
REMARK 500 ARG B 193 14.72 -68.62
REMARK 500 HIS B 243 78.76 58.36
REMARK 500 SER B 245 -148.77 -140.48
REMARK 500 PRO B 340 -30.51 -38.90
REMARK 500 ARG B 388 74.29 58.30
REMARK 500
REMARK 500 REMARK: NULL
REMARK 620
REMARK 620 METAL COORDINATION
REMARK 620 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER;
REMARK 620 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE):
REMARK 620
REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL
REMARK 620 MG A 536 MG
REMARK 620 N RES CSSEQI ATOM
REMARK 620 1 ASN A 199 ND2
REMARK 620 2 ASP A 212 OD2 61.9
REMARK 620 3 ATP A 535 O2G 157.8 125.9
REMARK 620 4 ATP A 535 O3B 112.0 169.8 63.1
REMARK 620 5 ATP A 535 O1B 91.4 116.2 100.9 54.3
REMARK 620 6 ATP A 535 O2A 126.3 81.3 75.5 97.6 70.5
REMARK 620 N 1 2 3 4 5
REMARK 620
REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL
REMARK 620 MG B 538 MG
REMARK 620 N RES CSSEQI ATOM
REMARK 620 1 ASN B 199 OD1
REMARK 620 2 ASP B 212 OD2 73.7
REMARK 620 3 ATP B 537 O2A 165.5 95.3
REMARK 620 4 ATP B 537 O1B 96.7 145.8 87.3
REMARK 620 5 ATP B 537 O2G 114.5 146.5 79.9 67.5
REMARK 620 N 1 2 3 4
REMARK 800
REMARK 800 SITE
REMARK 800 SITE_IDENTIFIER: AC1
REMARK 800 EVIDENCE_CODE: SOFTWARE
REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE MG A 536
REMARK 800
REMARK 800 SITE_IDENTIFIER: AC2
REMARK 800 EVIDENCE_CODE: SOFTWARE
REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE MG B 538
REMARK 800
REMARK 800 SITE_IDENTIFIER: AC3
REMARK 800 EVIDENCE_CODE: SOFTWARE
REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE ATP A 535
REMARK 800
REMARK 800 SITE_IDENTIFIER: AC4
REMARK 800 EVIDENCE_CODE: SOFTWARE
REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE ATP B 537
REMARK 800
REMARK 800 SITE_IDENTIFIER: AC5
REMARK 800 EVIDENCE_CODE: SOFTWARE
REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE 5EA A 1001
REMARK 800
REMARK 800 SITE_IDENTIFIER: AC6
REMARK 800 EVIDENCE_CODE: SOFTWARE
REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE 5EA B 1002
REMARK 900
REMARK 900 RELATED ENTRIES
REMARK 900 RELATED ID: 1S9J RELATED DB: PDB
DBREF 1S9I A 55 400 UNP P36507 MP2K2_HUMAN 55 400
DBREF 1S9I B 55 400 UNP P36507 MP2K2_HUMAN 55 400
SEQADV 1S9I LEU A 401 UNP P36507 CLONING ARTIFACT
SEQADV 1S9I GLU A 402 UNP P36507 CLONING ARTIFACT
SEQADV 1S9I HIS A 403 UNP P36507 EXPRESSION TAG
SEQADV 1S9I HIS A 404 UNP P36507 EXPRESSION TAG
SEQADV 1S9I HIS A 405 UNP P36507 EXPRESSION TAG
SEQADV 1S9I HIS A 406 UNP P36507 EXPRESSION TAG
SEQADV 1S9I HIS A 407 UNP P36507 EXPRESSION TAG
SEQADV 1S9I HIS A 408 UNP P36507 EXPRESSION TAG
SEQADV 1S9I LEU B 401 UNP P36507 CLONING ARTIFACT
SEQADV 1S9I GLU B 402 UNP P36507 CLONING ARTIFACT
SEQADV 1S9I HIS B 403 UNP P36507 EXPRESSION TAG
SEQADV 1S9I HIS B 404 UNP P36507 EXPRESSION TAG
SEQADV 1S9I HIS B 405 UNP P36507 EXPRESSION TAG
SEQADV 1S9I HIS B 406 UNP P36507 EXPRESSION TAG
SEQADV 1S9I HIS B 407 UNP P36507 EXPRESSION TAG
SEQADV 1S9I HIS B 408 UNP P36507 EXPRESSION TAG
SEQRES 1 A 354 GLU ALA PHE LEU THR GLN LYS ALA LYS VAL GLY GLU LEU
SEQRES 2 A 354 LYS ASP ASP ASP PHE GLU ARG ILE SER GLU LEU GLY ALA
SEQRES 3 A 354 GLY ASN GLY GLY VAL VAL THR LYS VAL GLN HIS ARG PRO
SEQRES 4 A 354 SER GLY LEU ILE MET ALA ARG LYS LEU ILE HIS LEU GLU
SEQRES 5 A 354 ILE LYS PRO ALA ILE ARG ASN GLN ILE ILE ARG GLU LEU
SEQRES 6 A 354 GLN VAL LEU HIS GLU CYS ASN SER PRO TYR ILE VAL GLY
SEQRES 7 A 354 PHE TYR GLY ALA PHE TYR SER ASP GLY GLU ILE SER ILE
SEQRES 8 A 354 CYS MET GLU HIS MET ASP GLY GLY SER LEU ASP GLN VAL
SEQRES 9 A 354 LEU LYS GLU ALA LYS ARG ILE PRO GLU GLU ILE LEU GLY
SEQRES 10 A 354 LYS VAL SER ILE ALA VAL LEU ARG GLY LEU ALA TYR LEU
SEQRES 11 A 354 ARG GLU LYS HIS GLN ILE MET HIS ARG ASP VAL LYS PRO
SEQRES 12 A 354 SER ASN ILE LEU VAL ASN SER ARG GLY GLU ILE LYS LEU
SEQRES 13 A 354 CYS ASP PHE GLY VAL SER GLY GLN LEU ILE ASP SER MET
SEQRES 14 A 354 ALA ASN SER PHE VAL GLY THR ARG SER TYR MET ALA PRO
SEQRES 15 A 354 GLU ARG LEU GLN GLY THR HIS TYR SER VAL GLN SER ASP
SEQRES 16 A 354 ILE TRP SER MET GLY LEU SER LEU VAL GLU LEU ALA VAL
SEQRES 17 A 354 GLY ARG TYR PRO ILE PRO PRO PRO ASP ALA LYS GLU LEU
SEQRES 18 A 354 GLU ALA ILE PHE GLY ARG PRO VAL VAL ASP GLY GLU GLU
SEQRES 19 A 354 GLY GLU PRO HIS SER ILE SER PRO ARG PRO ARG PRO PRO
SEQRES 20 A 354 GLY ARG PRO VAL SER GLY HIS GLY MET ASP SER ARG PRO
SEQRES 21 A 354 ALA MET ALA ILE PHE GLU LEU LEU ASP TYR ILE VAL ASN
SEQRES 22 A 354 GLU PRO PRO PRO LYS LEU PRO ASN GLY VAL PHE THR PRO
SEQRES 23 A 354 ASP PHE GLN GLU PHE VAL ASN LYS CYS LEU ILE LYS ASN
SEQRES 24 A 354 PRO ALA GLU ARG ALA ASP LEU LYS MET LEU THR ASN HIS
SEQRES 25 A 354 THR PHE ILE LYS ARG SER GLU VAL GLU GLU VAL ASP PHE
SEQRES 26 A 354 ALA GLY TRP LEU CYS LYS THR LEU ARG LEU ASN GLN PRO
SEQRES 27 A 354 GLY THR PRO THR ARG THR ALA VAL LEU GLU HIS HIS HIS
SEQRES 28 A 354 HIS HIS HIS
SEQRES 1 B 354 GLU ALA PHE LEU THR GLN LYS ALA LYS VAL GLY GLU LEU
SEQRES 2 B 354 LYS ASP ASP ASP PHE GLU ARG ILE SER GLU LEU GLY ALA
SEQRES 3 B 354 GLY ASN GLY GLY VAL VAL THR LYS VAL GLN HIS ARG PRO
SEQRES 4 B 354 SER GLY LEU ILE MET ALA ARG LYS LEU ILE HIS LEU GLU
SEQRES 5 B 354 ILE LYS PRO ALA ILE ARG ASN GLN ILE ILE ARG GLU LEU
SEQRES 6 B 354 GLN VAL LEU HIS GLU CYS ASN SER PRO TYR ILE VAL GLY
SEQRES 7 B 354 PHE TYR GLY ALA PHE TYR SER ASP GLY GLU ILE SER ILE
SEQRES 8 B 354 CYS MET GLU HIS MET ASP GLY GLY SER LEU ASP GLN VAL
SEQRES 9 B 354 LEU LYS GLU ALA LYS ARG ILE PRO GLU GLU ILE LEU GLY
SEQRES 10 B 354 LYS VAL SER ILE ALA VAL LEU ARG GLY LEU ALA TYR LEU
SEQRES 11 B 354 ARG GLU LYS HIS GLN ILE MET HIS ARG ASP VAL LYS PRO
SEQRES 12 B 354 SER ASN ILE LEU VAL ASN SER ARG GLY GLU ILE LYS LEU
SEQRES 13 B 354 CYS ASP PHE GLY VAL SER GLY GLN LEU ILE ASP SER MET
SEQRES 14 B 354 ALA ASN SER PHE VAL GLY THR ARG SER TYR MET ALA PRO
SEQRES 15 B 354 GLU ARG LEU GLN GLY THR HIS TYR SER VAL GLN SER ASP
SEQRES 16 B 354 ILE TRP SER MET GLY LEU SER LEU VAL GLU LEU ALA VAL
SEQRES 17 B 354 GLY ARG TYR PRO ILE PRO PRO PRO ASP ALA LYS GLU LEU
SEQRES 18 B 354 GLU ALA ILE PHE GLY ARG PRO VAL VAL ASP GLY GLU GLU
SEQRES 19 B 354 GLY GLU PRO HIS SER ILE SER PRO ARG PRO ARG PRO PRO
SEQRES 20 B 354 GLY ARG PRO VAL SER GLY HIS GLY MET ASP SER ARG PRO
SEQRES 21 B 354 ALA MET ALA ILE PHE GLU LEU LEU ASP TYR ILE VAL ASN
SEQRES 22 B 354 GLU PRO PRO PRO LYS LEU PRO ASN GLY VAL PHE THR PRO
SEQRES 23 B 354 ASP PHE GLN GLU PHE VAL ASN LYS CYS LEU ILE LYS ASN
SEQRES 24 B 354 PRO ALA GLU ARG ALA ASP LEU LYS MET LEU THR ASN HIS
SEQRES 25 B 354 THR PHE ILE LYS ARG SER GLU VAL GLU GLU VAL ASP PHE
SEQRES 26 B 354 ALA GLY TRP LEU CYS LYS THR LEU ARG LEU ASN GLN PRO
SEQRES 27 B 354 GLY THR PRO THR ARG THR ALA VAL LEU GLU HIS HIS HIS
SEQRES 28 B 354 HIS HIS HIS
HET MG A 536 1
HET ATP A 535 31
HET 5EA A1001 31
HET MG B 538 1
HET ATP B 537 31
HET 5EA B1002 31
HETNAM MG MAGNESIUM ION
HETNAM ATP ADENOSINE-5'-TRIPHOSPHATE
HETNAM 5EA 5-{3,4-DIFLUORO-2-[(2-FLUORO-4-IODOPHENYL)
HETNAM 2 5EA AMINO]PHENYL}-N-(2-MORPHOLIN-4-YLETHYL)-1,3,4-
HETNAM 3 5EA OXADIAZOL-2-AMINE
FORMUL 3 MG 2(MG 2+)
FORMUL 4 ATP 2(C10 H16 N5 O13 P3)
FORMUL 5 5EA 2(C20 H19 F3 I N5 O2)
HELIX 1 1 LYS A 68 ASP A 70 5 3
HELIX 2 2 PRO A 109 GLN A 120 1 12
HELIX 3 3 VAL A 121 HIS A 123 5 3
HELIX 4 4 LEU A 155 ALA A 162 1 8
HELIX 5 5 PRO A 166 LYS A 187 1 22
HELIX 6 6 LYS A 196 SER A 198 5 3
HELIX 7 7 SER A 216 MET A 223 1 8
HELIX 8 8 ALA A 235 GLN A 240 1 6
HELIX 9 9 SER A 245 GLY A 263 1 19
HELIX 10 10 ASP A 271 GLY A 280 1 10
HELIX 11 11 ALA A 317 GLU A 328 1 12
HELIX 12 12 THR A 339 LEU A 350 1 12
HELIX 13 13 ASP A 359 ASN A 365 1 7
HELIX 14 14 HIS A 366 GLU A 375 1 10
HELIX 15 15 ASP A 378 LEU A 387 1 10
HELIX 16 16 ILE B 111 LEU B 119 1 9
HELIX 17 17 GLN B 120 CYS B 125 5 6
HELIX 18 18 LEU B 155 ALA B 162 1 8
HELIX 19 19 PRO B 166 LYS B 187 1 22
HELIX 20 20 LYS B 196 SER B 198 5 3
HELIX 21 21 SER B 216 SER B 222 1 7
HELIX 22 22 ALA B 235 GLY B 241 1 7
HELIX 23 23 VAL B 246 GLY B 263 1 18
HELIX 24 24 GLU B 274 ILE B 278 5 5
HELIX 25 25 ALA B 317 GLU B 328 1 12
HELIX 26 26 THR B 339 LEU B 350 1 12
HELIX 27 27 ASP B 359 ASN B 365 1 7
HELIX 28 28 HIS B 366 VAL B 374 1 9
HELIX 29 29 ASP B 378 ARG B 388 1 11
SHEET 1 A 5 PHE A 72 ALA A 80 0
SHEET 2 A 5 VAL A 85 HIS A 91 -1 O LYS A 88 N SER A 76
SHEET 3 A 5 ILE A 97 ILE A 103 -1 O MET A 98 N VAL A 89
SHEET 4 A 5 ILE A 143 GLU A 148 -1 O MET A 147 N ALA A 99
SHEET 5 A 5 PHE A 133 TYR A 138 -1 N GLY A 135 O CYS A 146
SHEET 1 B 3 GLY A 153 SER A 154 0
SHEET 2 B 3 ILE A 200 VAL A 202 -1 O VAL A 202 N GLY A 153
SHEET 3 B 3 ILE A 208 LEU A 210 -1 O LYS A 209 N LEU A 201
SHEET 1 C 5 PHE B 72 GLY B 81 0
SHEET 2 C 5 GLY B 84 HIS B 91 -1 O GLY B 84 N GLY B 81
SHEET 3 C 5 ILE B 97 HIS B 104 -1 O LEU B 102 N VAL B 85
SHEET 4 C 5 GLU B 142 GLU B 148 -1 O ILE B 145 N LYS B 101
SHEET 5 C 5 PHE B 133 SER B 139 -1 N GLY B 135 O CYS B 146
SHEET 1 D 3 GLY B 153 SER B 154 0
SHEET 2 D 3 ILE B 200 VAL B 202 -1 O VAL B 202 N GLY B 153
SHEET 3 D 3 ILE B 208 LEU B 210 -1 O LYS B 209 N LEU B 201
LINK ND2 ASN A 199 MG MG A 536 1555 1555 2.55
LINK OD2 ASP A 212 MG MG A 536 1555 1555 2.44
LINK O2G ATP A 535 MG MG A 536 1555 1555 2.54
LINK O3B ATP A 535 MG MG A 536 1555 1555 2.15
LINK O1B ATP A 535 MG MG A 536 1555 1555 3.02
LINK O2A ATP A 535 MG MG A 536 1555 1555 2.08
LINK OD1 ASN B 199 MG MG B 538 1555 1555 2.27
LINK OD2 ASP B 212 MG MG B 538 1555 1555 2.55
LINK O2A ATP B 537 MG MG B 538 1555 1555 1.91
LINK O1B ATP B 537 MG MG B 538 1555 1555 2.19
LINK O2G ATP B 537 MG MG B 538 1555 1555 2.83
CISPEP 1 VAL A 64 GLY A 65 0 -6.41
CISPEP 2 GLY A 280 ARG A 281 0 9.33
SITE 1 AC1 3 ASN A 199 ASP A 212 ATP A 535
SITE 1 AC2 3 ASN B 199 ASP B 212 ATP B 537
SITE 1 AC3 18 LEU A 78 GLY A 81 ASN A 82 VAL A 86
SITE 2 AC3 18 ALA A 99 LYS A 101 MET A 147 GLU A 148
SITE 3 AC3 18 MET A 150 SER A 154 GLN A 157 ASP A 194
SITE 4 AC3 18 LYS A 196 SER A 198 LEU A 201 ASP A 212
SITE 5 AC3 18 MG A 536 5EA A1001
SITE 1 AC4 19 LEU B 78 GLY B 79 GLY B 81 ASN B 82
SITE 2 AC4 19 GLY B 84 ALA B 99 LYS B 101 MET B 147
SITE 3 AC4 19 GLU B 148 MET B 150 SER B 154 GLN B 157
SITE 4 AC4 19 LYS B 196 SER B 198 ASN B 199 LEU B 201
SITE 5 AC4 19 ASP B 212 MG B 538 5EA B1002
SITE 1 AC5 15 ASN A 82 LYS A 101 LEU A 119 LEU A 122
SITE 2 AC5 15 VAL A 131 MET A 147 ARG A 193 ASP A 194
SITE 3 AC5 15 ASP A 212 PHE A 213 GLY A 214 VAL A 215
SITE 4 AC5 15 SER A 216 MET A 223 ATP A 535
SITE 1 AC6 12 LYS B 101 LEU B 119 LEU B 122 VAL B 131
SITE 2 AC6 12 ASP B 212 PHE B 213 GLY B 214 VAL B 215
SITE 3 AC6 12 SER B 216 LEU B 219 MET B 223 ATP B 537
CRYST1 161.888 161.888 122.986 90.00 90.00 120.00 P 61 2 2 24
ORIGX1 1.000000 0.000000 0.000000 0.00000
ORIGX2 0.000000 1.000000 0.000000 0.00000
ORIGX3 0.000000 0.000000 1.000000 0.00000
SCALE1 0.006177 0.003566 0.000000 0.00000
SCALE2 0.000000 0.007133 0.000000 0.00000
SCALE3 0.000000 0.000000 0.008131 0.00000